云南宫腔镜实训平台(电刀系统)-【嘉大嘉拟】,嘉大智创,郑州高智能心肺复苏自助考核平台,天水头颈部浅层解剖模型,开放式医学影像辅助教学系统厂家直销,长沙肩关节附矢状剖面模型,青海口腔修复套装,承德医学腹部切开缝合训练模型
云南宫腔镜实训平台(电刀系统)福建颈部中层解剖模型,高级婴儿头部综合静脉穿刺模型,保山脊柱骨模型,上海60CM 男性针灸模型解剖(中英代),沈阳腰椎穿刺训练仿真标准化病人,重庆小儿骨穿及股静脉穿刺操作模型,福建中医舌象诊断系统
BEIJING, Feb.11 (Xinhua) -- Representatives from different sectors have given feedback on drafts of the government work report and China's economic and social development blueprint for the next five years, the State Council, China's cabinet, said Friday.Premier Wen Jiabao chaired five seminars from Jan. 20 to 27, at which representatives of various sectors of society were invited to voice their views on the documents, according to a State Council statement.The 12th five-year program, or the national development plan for 2011 to 2015, and the government work report will be delivered for review at the plenary session of the National People's Congress (NPC), China's top legislature, in March.Experts from social economic organizations along with those from science and technology, education, health, culture and sports circles attended the meetings, as well as members of non-communist parties.Participants at the seminars agreed on the framework and main content of the documents. They also gave some suggestions and proposed a couple of revisions to the report and the development plan.Most suggestions focused on China's economic restructuring, income distribution adjustment, modern agricultural development, scientific innovation, reform of the yuan exchange rate formation mechanism, property market regulation and affordable housing construction, and further improvement in education and medical care system.The forums also invited 11 grass-roots representatives, including farmers, technicians, and owners of small businesses, who raised suggestions to boost farmland irrigation construction, train more technicians, and help with the development of small and medium enterprises.Wen said the feedback will be "of great help" when revising both the government work report and 12th five-year plan, as well as to the work of the government.
WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.
BEIJING, March 15 (Xinhuanet) -- The number of Alzheimer patients is growing rapidly, so is that of unpaid caregivers, says a report released Tuesday by the Alzheimer's Association.Nearly 15 million caregivers, most of them family members but also friends, are providing billions of hours of unpaid care for Alzheimer's patients and other forms of dementia in the U.S. — 37 percent more than last year, the report says.Alzheimer's is the sixth leading cause of death in the nation, and the only one among the top 10 that have no prevention or cure, says William Thies, chief medical and scientific officer of the Alzheimer's Association.However, if people were more aware of early symptoms and were diagnosed sooner, then planning could help ease stress on patients and caregivers, according to Beth Kallmyer, senior director of constituent services of Alzheimer's Association."The toll on families is devastating," says Kallmyer, "Stress is extremely high, and one-third are experiencing depression."The time and stress of caring for an Alzheimer’s patient takes a physical toll, translating into nearly 8 billion dollars worth of extra health care costs for caregivers, the report says.
LOS ANGELES, April 10 (Xinhua) -- Drinking green tea and practicing Taichi may promote bone health of postmenopausal women and reduce the risk of inflammation, a new study suggests.The study, conducted by researchers at the Laura W. Bush Institute for Women's Health at the Texas Tech University Health Sciences Center, focused on postmenopausal women and investigated the potential for green tea to work synergistically with Taichi in enhancing bone strength of postmenopausal women.Originating as a martial art in China, Taichi is a mind-body exercise that utilizes slow, gentle movements to build strength and flexibility, as well as deep breathing and relaxation, to move qi, or vital energy, throughout the body.The study findings were published Sunday at EurekAlert.org, the website of the American Association for the Advancement of Science (AAAS).Carried out as a double-blind, placebo-controlled, intervention trial (the "holy grail" of scientific studies), this experiment involved 171 postmenopausal women with the average age of 57 who had weak bones but not full-fledged osteoporosis. Subjects were divided into 4 groups -- placebo: starch pill (placebo) and no Taichi; GTP or green tea polyphenols (500 mg/day) and no Taichi; Placebo plus Taichi (starch pill and practising Taichi three times a week); and GTP plus Taichi.The study lasted for 6 months, during which blood and urine samples were collected and muscle strength assessed.The results show that consumption of GTP (at a level equivalent to about four-six cups of steeped green tea daily) and participation in Taichi independently enhanced markers of bone health by three and six months, respectively. A similar effect was found for muscle strength at the 6-month time point. Participants taking Taichi classes also reported significant beneficial effects in quality of life in terms of improving their emotional and mental health.Perhaps most remarkable, however, was the substantial effect that both GTP and Taichi had on biological markers of oxidative stress. Because oxidative stress is a main precursor to inflammation, this finding suggests that green tea and Taichi may help reduce the underlying etiology of not only osteoporosis, but other inflammatory diseases as well.In the study, the researchers developed an animal model (the ovariectomized, middle-aged female rat), with which they could effectively study the effects of green tea consumption on protection against breakdown of the bone's microarchitecture, according to the AAAS.In humans, this can lead to osteoporosis, a condition common to older women. The researchers say what they have learned from the animal models might also be applicable to postmenopausal women.There is a "favorable effect of modest green tea consumption on bone remodeling in this pre-osteoporotic population," said lead researcher Dr. Chwan-Li (Leslie) Shen, an associate professor at the institute.The researchers plan to soon complete a more long-term study utilizing more technically savvy measures of bone density, according to the AAAS.